Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  La Jolla Pharmaceutical Company    LJPCD

SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

LA JOLLA PHARMACEUTICAL COMPANY : REVERSE SPLIT: 1 of 50

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/14/2014 CET
A split is applied today to La Jolla Pharmaceutical Company's stock price.


© Factset 2014
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LA JOLLA PHARMACEUTICAL CO
01/20 LA JOLLA PHARMACEUTICAL : Sepsis Alliance Announces National Partnership with La..
01/05 LA JOLLA PHARMACEUTICAL COMPANY (NAS : LJPC) Files An 8-K Entry into a Material ..
01/05 LA JOLLA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement, Creatio..
2016 LA JOLLA PHARMACEUTICAL COMPANY : Announces Financial Results for the Three and ..
2016 LA JOLLA PHARMACEUTICAL CO : Results of Operations and Financial Condition, Fina..
2016 LA JOLLA PHARMACEUTICAL COMPANY : Announces Financial Results for the Three and ..
2016 LA JOLLA PHARMACEUTICAL : posts 3Q loss
2016 LA JOLLA PHARMACEUTICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
2016 LA JOLLA PHARMACEUTICAL COMPANY : Announces Financial Results for the Three and ..
2016 LA JOLLA PHARMACEUTICAL COMPANY : Receives Positive Opinion from European Orphan..
More news
Sector news : Bio Therapeutic Drugs
01/13DJNOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs
01/12 Investors in big pharma, biotech look to ride out Trump storm
01/12DJHot Stocks to Watch in the U.S. and Canada
01/10 Regeneron CEO says Amgen not putting patients first in patent dispute
01/09DJCELGENE : Anticipates Slowing Sales Growth for Main Drug Revlimid
More sector news : Bio Therapeutic Drugs
Advertisement
Financials ($)
Sales 2016 1,66 M
EBIT 2016 -74,5 M
Net income 2016 -74,4 M
Debt 2016 -
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 220x
Capi. / Sales 2017 1 014x
Capitalization 364 M
More Financials
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 43,4 $
Spread / Average Target 118%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
George Francis Tidmarsh President, CEO, Secretary & Director
Kevin C. Tang Chairman
Jennifer Carver Senior Vice President-Operations
Dennis M. Mulroy Chief Financial & Accounting Officer
Lakhmir S. Chawla Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
LA JOLLA PHARMACEUTICA..0.00%364
AMGEN, INC.5.19%114 415
GILEAD SCIENCES, INC.-0.06%94 290
CELGENE CORPORATION-1.84%88 079
REGENERON PHARMACEUTIC..-1.00%38 329
ACTELION LTD4.58%24 308
More Results